Neurolymphomatosis (NL) is a rare manifestation of lymphoma [1] . CT and MRI have been used to detect NL, to stage the extent of the nerve involvement and to guide biopsy. Recent reports have demonstrated the value of FDG-PET/CT in patients with NL [2] [3] [4] . Here we present the FDG-PET/CT imaging follow-up of a 56-yearold patient with diffuse large B-cell lymphoma initially presenting as stage IE involving the urinary bladder and presacral area. After six cycles of chemotherapy and pelvic radiation therapy, a complete response was documented. However, there was relapse of the lymphoma, restricted to neural structures. In a-c the PET/CT images demonstrate increased FDG uptake in the cranial nerves, delineated on fused axial images [b, gasserian ganglion of the trigeminal nerve (arrows) and c the cervical and lumbar nerve roots (arrows)]. The patient was treated with high-dose methotrexate and subsequent radiation therapy. Six weeks after the end of radiation therapy, progressive NL (d-f) in the brachial (e, arrows) and lumbosacral plexus (f, arrows) was observed.
Because in NL nerve biopsies may fail and MRI may not be sufficiently sensitive to show the entire extent of nerve involvement, FDG-PET/CT with whole-body imaging and exact anatomical correlation is useful in staging, biopsy guidance, treatment planning and therapy assessment [5] .
